Voglibose 0.2 Mg Mouth Dissolving

Voglibose 0.2 MG Tablet exactly as prescribed by your doctor. It is advised to take this medicine just before meals.

Store at a controlled room temperature between 15 and 30 degrees C (59 and 86 degrees F); protect from light and moisture.

Diarrhoea, Flatulence, Pneumatosis Intestinalis, Abnormal Liver Function, Nausea Or Vomiting, Dizziness.

Use of this medicine is not recommended during pregnancies as the possible effect on developing fetus is unknown. It is recommended to discontinue the consumption of this medicine if you are pregnant or planning to become pregnant. Consult your doctor before stopping the use of this medication so that an alternate medication can be prescribed.

Patients should be monitored regularly for signs of hypoglycemia, especially when Voglibose + Glimepiride + Metformin is used in combination with other antidiabetic medications. This medication should be used with caution in patients with renal impairment, as metformin is primarily excreted by the kidneys, and dose adjustments may be necessary to prevent adverse effects. Voglibose + Glimepiride + Metformin should not be used in patients with type 1 diabetes mellitus or diabetic ketoacidosis. Patients should be advised to adhere to a regular meal schedule and monitor blood sugar levels closely while taking this medication.

Voglibose - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2021 [cited 03 December 2021]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/444020 Voglibose - DrugBank [Internet]. Drugbank.ca. 2021 [cited 3 December 2021]. Available from: https://go.drugbank.com/drugs/DB04878.

Voglibose inhibits alpha-glucosidase enzymes in the small intestine, delaying the digestion and absorption of carbohydrates. This results in a reduction in postprandial blood glucose levels.

DIABETIC